Literature DB >> 8678837

A variant of MDCK cell line which restricted growth of influenza viruses mainly through suppression of viral primary transcription.

H Jin1, M Urabe, K Tobita.   

Abstract

By serial subculture of MDCK cells which survived high multiplicity infections with AWBY-140, a weakly cytolytic mutant of influenza virus A/WSN (H1N1), we established a variant cell line (MDCK-L cells) that was uniquely resistant to infection with influenza A and B viruses, yielding 3 to 4 orders lower amount of progeny virus compared with MDCK cells. Competitive polymerase chain reaction revealed that the amount of primary transcript produced in MDCK-L cells infected with 10 PFU/cell of influenza virus A/Aichi was suppressed to 1/100 of that in MDCK cells similarly infected, although the amount of virus adsorbed to MDCK-L cells was 1/4 of MDCK cells. Even when MDCLK-L cells were infected with 40 PFU/cell of Aichi to overcome the lower amount of internalized virus in those cells, the results were the same. The synthesis of v-, c- and mRNAs, as well as proteins of infected A/Aichi was below detectable level in MDCK-L cells, in contrast with MDCK cells, where they were clearly demonstrable by ribonuclease protection assay or polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8678837     DOI: 10.1007/bf01718166

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Transport of incoming influenza virus nucleocapsids into the nucleus.

Authors:  K Martin; A Helenius
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

2.  Immunofluorescence of abortive and complete infections by influenza A virus in hamster BHK21 cells and mouse L cells.

Authors:  K B Fraser
Journal:  J Gen Virol       Date:  1967-01       Impact factor: 3.891

3.  Persistence of viral genes in a variant of MDBK cell after productive replication of a mutant of influenza virus A/WSN.

Authors:  M Urabe; T Tanaka; T Odagiri; M Tashiro; K Tobita
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

4.  An amino acid change in the non-structural NS2 protein of an influenza A virus mutant is responsible for the generation of defective interfering (DI) particles by amplifying DI RNAs and suppressing complementary RNA synthesis.

Authors:  T Odagiri; K Tominaga; K Tobita; S Ohta
Journal:  J Gen Virol       Date:  1994-01       Impact factor: 3.891

5.  Abortive replication of influenza virus A/WSN/33 in HeLa229 cells: defective viral entry and budding processes.

Authors:  C N Gujuluva; A Kundu; K G Murti; D P Nayak
Journal:  Virology       Date:  1994-11-01       Impact factor: 3.616

6.  Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells.

Authors:  C Herz; E Stavnezer; R Krug; T Gurney
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

7.  Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses.

Authors:  K Tobita
Journal:  Med Microbiol Immunol       Date:  1975-12-30       Impact factor: 3.402

8.  Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction.

Authors:  G Gilliland; S Perrin; K Blanchard; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

9.  The multiplication of an influenza C virus in an established line of canine kidney (MDCK) cells.

Authors:  K Nerome; M Ishida
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

10.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs.

Authors:  G I Shapiro; T Gurney; R M Krug
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

View more
  3 in total

1.  Impact of the segment-specific region of the 3'-untranslated region of the influenza A virus PB1 segment on protein expression.

Authors:  Jun Ma; Kang Liu; Chunyi Xue; Jianqiang Zhou; Shun Xu; Yida Ren; Jing Zheng; Yongchang Cao
Journal:  Virus Genes       Date:  2013-08-15       Impact factor: 2.332

2.  Synthetic sialylphosphatidylethanolamine derivatives bind to human influenza A viruses and inhibit viral infection.

Authors:  C T Guo; C H Wong; T Kajimoto; T Miura; Y Ida; L R Juneja; M J Kim; H Masuda; T Suzuki; Y Suzuki
Journal:  Glycoconj J       Date:  1998-11       Impact factor: 2.916

3.  An Anti-Influenza Virus Antibody Inhibits Viral Infection by Reducing Nucleus Entry of Influenza Nucleoprotein.

Authors:  Aerin Yoon; Kye Sook Yi; So Young Chang; Sung Hwan Kim; Manki Song; Jung Ah Choi; Melissa Bourgeois; M Jaber Hossain; Li-Mei Chen; Ruben O Donis; Hyori Kim; Yujean Lee; Do Been Hwang; Ji-Young Min; Shin Jae Chang; Junho Chung
Journal:  PLoS One       Date:  2015-10-29       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.